J Gastric Cancer.
2022 Oct;22(4):306-318. 10.5230/jgc.2022.22.e28.
Urinary Biomarkers for the Noninvasive Detection of Gastric Cancer
- Affiliations
-
- 1Gansu Provincial Clinical Research Center for Laboratory Medicine, Lanzhou, China
- 2Department of Clinical Laboratory, Gansu Provincial Hospital, Lanzhou, China
- KMID: 2535114
- DOI: http://doi.org/10.5230/jgc.2022.22.e28
Abstract
- Gastric cancer (GC) is associated with high morbidity and mortality rates. Thus, early diagnosis is important to improve disease prognosis. Endoscopic assessment represents the most reliable imaging method for GC diagnosis; however, it is semi-invasive and costly and heavily depends on the skills of the endoscopist, which limit its clinical applicability. Therefore, the search for new sensitive biomarkers for the early detection of GC using noninvasive sampling collection methods has attracted much attention among scientists. Urine is considered an ideal biofluid, as it is readily accessible, less complex, and relatively stable than plasma and serum. Over the years, substantial progress has been made in screening for potential urinary biomarkers for GC. This review explores the possible applications and limitations of urinary biomarkers in GC detection and diagnosis.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Urinary Biomarker in Bladder Cancer at Present Time
- Liquid biopsy? A recent breakthrough in noninvasive bladder cancer surveillance
- Circulating Cell-free Tumor Nucleic Acids in Gastric Cancer
- Detection of Methylated Circulating DNA as Noninvasive Biomarkers for Breast Cancer Diagnosis
- For Physicians Managing Voiding Dysfunction, Improving the Detection Rate of Early Prostate Cancer and Discrimination From Benign Prostatic Hyperplasia, in a Molecular Biomarker Aspects
